Telmisartan Plus Tablet 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
YuYu Pharmaceutical Co., Ltd.
MFDS item code 201902126 · Approved 2019.04.08
This product's status changed to Expired on 2024.04.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used in patients with essential hypertension who do not have sufficient blood pressure control with either amlodipine or telmisartan monotherapy. It helps prevent cardiovascular complications and maintain health by better managing blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with an individual component as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This drug can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. Patients allergic to any of the main ingredients or related components of this drug, breastfeeding women, patients with severe liver or heart problems, patients with severe hypotension, etc., should not take this drug. Patients with primary aldosteronism or certain heart valve diseases, patients with impaired liver function, patients with gastrointestinal disorders, patients with renal vascular issues, patients with renal failure requiring dialysis, elderly patients, etc., should use this drug with caution. Common side effects such as dizziness or edema may occur when taking this drug, and, rarely, severe allergic reactions or heart problems may arise. This drug should not be used during pregnancy, and if pregnancy is confirmed, treatment should be discontinued immediately and alternative therapies should be initiated. Hypotension may occur, so patients with insufficient fluids or salts should adjust their condition before taking the drug, and if symptoms of hypotension appear during treatment, appropriate measures should be taken immediately. As there is a risk of elevated potassium levels in the blood, caution is needed when taking potassium supplements or drugs containing potassium together. Patients with impaired kidney function should regularly monitor kidney function and electrolyte status through blood tests while taking this drug. Patients with heart disease should be cautious when taking this drug, as the risk of angina or myocardial infarction may increase. This drug may cause drowsiness or dizziness, so caution should be taken when driving or operating machinery. Interactions with other medications may occur, so it is important to consult healthcare professionals when taking this drug with digoxin, lithium, warfarin, certain analgesics, etc. Overdose of this drug may result in severe hypotension, dizziness, or impairment of heart function; immediate medical attention should be sought for appropriate treatment. Safety and efficacy have not been adequately established in children, so its use is not recommended. This drug should be kept out of the reach of children, maintained in its original packaging, and opened just before use.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light; therefore, it should be stored in a special container that does not allow light in. Moreover, it is important to store the medication at a cool room temperature, specifically between 1 to 30 degrees Celsius, to maintain its efficacy.
This is a double tablet that is oval-shaped with a convex double side, and is white and light gray.
30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
YuYu Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.